Carotid Body Removal for the Treatment of Resistant Hypertension: a Pilot Study
Primary Purpose
Hypertension
Status
Completed
Phase
Not Applicable
Locations
Poland
Study Type
Interventional
Intervention
Carotid body excision
Sponsored by

About this trial
This is an interventional treatment trial for Hypertension
Eligibility Criteria
Inclusion Criteria:
- Resistant HTN criteria with either confirmed sleep disordered breathing. Definition of HTN:Office SBP ≥ 160 mmHg and daytime mean ABPM ≥ 140 mm Hg
- Definition of sleep disordered breathing: SDB defined as mild to moderate obstructive, central or mixed sleep apnea defined as 5 < AHI < 30 with O2 desaturation not exceeding 80% during the night.
Exclusion Criteria:
- Calculated GFR < 30
- Carotid body located outside the defined carotid septum
- Obstructive carotid atherosclerotic disease
- Oxygen desaturation at rest below 92%
- Known structural lung disease (medical interview)
- Requirement for oxygen therapy to maintain oxygen saturation
- Patients wish to participate in mountain climbing, skin diving or free diving
- Pregnancy or anticipation of pregnancy
- Palliative care/chemotherapy
- Acute coronary syndrome or unstable angina < 6 months prior to procedure
- Use of exogenous insulin AND history of hypoglycemic unawareness
- Stroke or transient ischaemic attack (TIA), or myocardial infarction < 6 months prior to procedure
- Expected life expectancy less that 24months due to other disease
- Intravenous drug use
- Excessive use of alcohol or sedatives (Alcohol intake >28 units/week)
- Obesity (BMI > 40)
- Upper airway or facial abnormalities
- Large neck circumference (>43.2 cm men; >40.6 cm women)
- Febrile illness within two weeks of participation
- Unable to attend for follow up appointments at 1, 3 and 6 months post operatively.
Sites / Locations
- Department of Hypertension and Diabetology, Medical University of Gdansk
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Carotid body excision
Arm Description
Patients undergoing the carotid body excision to test the hypothesis that carotid body excision is sufficient to attain target blood pressure.
Outcomes
Primary Outcome Measures
Change of Blood Pressure
Change from Baseline Blood Pressure at 3 months
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01729988
Brief Title
Carotid Body Removal for the Treatment of Resistant Hypertension: a Pilot Study
Official Title
Carotid Body Removal for the Treatment of Resistant Hypertension: a Pilot Study
Study Type
Interventional
2. Study Status
Record Verification Date
October 2016
Overall Recruitment Status
Completed
Study Start Date
November 2012 (undefined)
Primary Completion Date
January 2016 (Actual)
Study Completion Date
January 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Noblewell
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This is a pilot study to assess the effectiveness, safety and feasibility of carotid body removal in patients with high blood pressure (hypertension) resistant to medical treatment. Patients with high blood pressure are at significant risk of medical complications including stroke and heart disease. The principle research question is whether removal of the carotid body will lead to an improvement in the blood pressure of this patient group.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
11 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Carotid body excision
Arm Type
Experimental
Arm Description
Patients undergoing the carotid body excision to test the hypothesis that carotid body excision is sufficient to attain target blood pressure.
Intervention Type
Procedure
Intervention Name(s)
Carotid body excision
Intervention Description
This surgery does not involve any study drug or investigational device.
The carotid body will be removed by the so called 'lateral approach' or a combined 'lateral and medial approach'. In all cases the target area was defined as the tissue in between the ECA and ICA, up to 5-6mm above the bifurcation point of the common carotid artery into the ECA and ICA. In a lateral approach the carotid bifurcation is not turned. A combined approach includes usually dissection of the superior thyroid vessel and turning of the carotid bifurcation.
Primary Outcome Measure Information:
Title
Change of Blood Pressure
Description
Change from Baseline Blood Pressure at 3 months
Time Frame
3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Resistant HTN criteria with either confirmed sleep disordered breathing. Definition of HTN:Office SBP ≥ 160 mmHg and daytime mean ABPM ≥ 140 mm Hg
Definition of sleep disordered breathing: SDB defined as mild to moderate obstructive, central or mixed sleep apnea defined as 5 < AHI < 30 with O2 desaturation not exceeding 80% during the night.
Exclusion Criteria:
Calculated GFR < 30
Carotid body located outside the defined carotid septum
Obstructive carotid atherosclerotic disease
Oxygen desaturation at rest below 92%
Known structural lung disease (medical interview)
Requirement for oxygen therapy to maintain oxygen saturation
Patients wish to participate in mountain climbing, skin diving or free diving
Pregnancy or anticipation of pregnancy
Palliative care/chemotherapy
Acute coronary syndrome or unstable angina < 6 months prior to procedure
Use of exogenous insulin AND history of hypoglycemic unawareness
Stroke or transient ischaemic attack (TIA), or myocardial infarction < 6 months prior to procedure
Expected life expectancy less that 24months due to other disease
Intravenous drug use
Excessive use of alcohol or sedatives (Alcohol intake >28 units/week)
Obesity (BMI > 40)
Upper airway or facial abnormalities
Large neck circumference (>43.2 cm men; >40.6 cm women)
Febrile illness within two weeks of participation
Unable to attend for follow up appointments at 1, 3 and 6 months post operatively.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Paul A. Sobotka, M.D.
Organizational Affiliation
Cibiem, Inc.
Official's Role
Study Director
Facility Information:
Facility Name
Department of Hypertension and Diabetology, Medical University of Gdansk
City
Gdansk
ZIP/Postal Code
80-952
Country
Poland
12. IPD Sharing Statement
Learn more about this trial
Carotid Body Removal for the Treatment of Resistant Hypertension: a Pilot Study
We'll reach out to this number within 24 hrs